Stock SCYX SCYNEXIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. SCYNEXIS, Inc.

Equities

SCYX

US8112922005

Real-time Estimate Cboe BZX
Other stock markets
 01:50:06 2024-05-03 pm EDT 		5-day change 1st Jan Change
1.72 USD -3.37% Intraday chart for SCYNEXIS, Inc. +11.14% -23.25%
Apr. 09 SCYNEXIS, Inc. to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases CI
Mar. 28 SCYNEXIS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ladenburg Thalmann Cuts SCYNEXIS Price Target to $7.50 From $15, Maintains Buy Rating
MT
Guggenheim Adjusts Price Target on SCYNEXIS to $9 From $8, Maintains Buy Rating
MT
Guggenheim Initiates SCYNEXIS at Buy With $8 Price Target
MT
Brookline Capital Assumes SCYNEXIS at Buy With $8 Price Target
MT
HC Wainwright Adjusts Price Target on SCYNEXIS to $8 From $14, Reiterates Buy Rating
MT
HC Wainwright Adjusts Price Target on SCYNEXIS to $14 From $20, Reiterates Buy Rating
MT
Maxim Group Adjusts SCYNEXIS Price Target to $11 From $16, Maintains Buy Rating
MT
SCYNEXIS : Aegis Capital Adjusts Price Target on SCYNEXIS to $35 From $40, Reiterates Buy Rating
MT
SCYNEXIS : Guggenheim Starts SCYNEXIS at Buy With $25 Price Target
MT
SCYNEXIS : Cantor Fitzgerald Starts SCYNEXIS at Overweight With $30 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SCYX Stock
  4. News SCYNEXIS, Inc.
  5. Analyst Reco.